Enalaprilat injection
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
|
USE IN PREGNANCY
See full prescribing information for complete Boxed Warning.
Condition Name: When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, Enalaprilat Injection, USP should be discontinued as soon as possible.
|
Overview
Enalaprilat injection is an Angiontensin converting enzyme inhibitor that is FDA approved for the {{{indicationType}}} of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. There is a Black Box Warning for this drug as shown here. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
<h4>Condition 1</h5>
- Dosing Information
- (Dosage)
Off-Label Use and Dosage (Adult)
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Enalaprilat injection FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Contraindications
There is limited information regarding Enalaprilat injection Contraindications in the drug label.
Warnings
|
USE IN PREGNANCY
See full prescribing information for complete Boxed Warning.
Condition Name: When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. When pregnancy is detected, Enalaprilat Injection, USP should be discontinued as soon as possible.
|
There is limited information regarding Enalaprilat injection Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Enalaprilat injection Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Enalaprilat injection Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Enalaprilat injection Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Enalaprilat injection in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Enalaprilat injection in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Enalaprilat injection during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Enalaprilat injection in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Enalaprilat injection in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Enalaprilat injection in geriatric settings.
Gender
There is no FDA guidance on the use of Enalaprilat injection with respect to specific gender populations.
Race
There is no FDA guidance on the use of Enalaprilat injection with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Enalaprilat injection in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Enalaprilat injection in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Enalaprilat injection in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Enalaprilat injection in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Enalaprilat injection Administration in the drug label.
Monitoring
There is limited information regarding Enalaprilat injection Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Enalaprilat injection and IV administrations.
Overdosage
There is limited information regarding Enalaprilat injection overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Enalaprilat injection Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Enalaprilat injection Mechanism of Action in the drug label.
Structure
There is limited information regarding Enalaprilat injection Structure in the drug label.
Pharmacodynamics
There is limited information regarding Enalaprilat injection Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Enalaprilat injection Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Enalaprilat injection Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Enalaprilat injection Clinical Studies in the drug label.
How Supplied
There is limited information regarding Enalaprilat injection How Supplied in the drug label.
Storage
There is limited information regarding Enalaprilat injection Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Enalaprilat injection |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Enalaprilat injection |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Enalaprilat injection Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Enalaprilat injection interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Enalaprilat injection Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Enalaprilat injection Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.